JENNIFER EDGAR: Open Payments
NPI 1174975262 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,148 in 98 payments from 32 companies in 2025. Trend: 2023 $954 · 2024 $1,761 · 2025 $2,148
Food & beverage: $2,148
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC | 18 | $341 |
| Supernus Pharmaceuticals, Inc. | 12 | $265 |
| UCB, Inc. | 13 | $215 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $91 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| Vanda Pharmaceuticals Inc. | 3 | $80 |
| CATALYST PHARMACEUTICALS, INC. | 3 | $75 |
| Eisai Inc. | 3 | $75 |
| Alexion Pharmaceuticals, Inc. | 3 | $74 |
| Genentech USA, Inc. | 3 | $73 |
Products named: CREXONT, Fintepla, HYQVIA, KESIMPTA, PONVORY, Leqembi, ULTOMIRIS, Ocrevus Zunovo.
Industry payments across MI — which companies pay providers there.
